WAO Presidential Message To Dr. Maeve O’Connor
Dear Dr. O’Connor,It’s that time of the year again when we are encouraged to reflect upon what that has been accomplished and what can improve for the coming year. 2023 was a transitional year for WAO. We ratified new members to the Board of Directors and Executive Committee. We organized three international meetings and symposia […]
Reductions in Infections and Associated Complications in Nine Common Variable Immunodeficiency Patients Treated with Immune globulin intravenous, human-slra
Common variable immunodeficiency (CVID) is a primary immune deficiency disease characterized by defects in humoral immunity. Individuals with CVID often experience frequent bacterial and viral infections of the upper airway, sinuses, and lungs despite standard immunoglobulin replacement therapy (IgRT). IgRT’s are subject to requirements established in 21 CFR 640 that define minimum concentrations for antibodies […]
The multifactorial impact of receiving a Hereditary Angioedema diagnosis
Co-Authors: Jason Raasch, MD, Mark Glaum, PhD, Maeve O’Connor, MD Abstract Hereditary angioedema (HAE) is a rare, chronic, debilitating genetic disorder characterized by recurrent, unpredictable, and potentially life-threatening episodes of swelling that typically affect the extremities, face, abdomen, genitals, and larynx. The most frequent cause of HAE is a mutation in the serpin family G member 1 (SERPING1) gene, which either […]
Blueprint Medicines Receives FDA Approval for AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis (ISM)
Blueprint Medicines Corporation announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT® (avapritinib) for the treatment of adults with Indolent Systemic Mastocytosis (ISM). All U.S. patients with ISM now have access to the first and only approved medicine designed to treat their disease. Systemic Mastocytosis (SM) is a rare hematologic disorder that […]
The Diagnostic Yield of Exome Sequencing in Predominantly Antibody Deficient Patients Followed in Private Practice Allergy/Immunology Clinics
Dr. Suez presented a late breaking PIDD Genetics Study poster on Saturday, May 20th, 2023. This year’s CIS Annual Meeting was held in St. Louis, MI at the Marriott St. Louis Grand.
CIIC APDS Poster Presented at AAAAI, 2023
Title: Approach to Identification of Patients with Activated Phosphoinositide-3 Kinase Delta Syndrome (APDS) Authors: D. Suez 1, R. Wasserman 2, A. Darter 3, E. Perez 4, J. Jacobs 5, D. Siri 6, D. Patterson 7, J. Offenberger 8, W. Lumry 9, M. Scarupa 10 1. Daniel Suez MD, Allergy, Asthma & Immunology Clinic PA, Irving […]
Amerimmune LLC Maintains Intellectual Property on the COVID-19 Related Use of Caspase Inhibitors as a Result of Histogen Inc. Led Arbitration
January 18th, 2023:MCLEAN, Va.–(BUSINESS WIRE)–Amerimmune LLC is a translational medicine biotechnology firm focused on discovery and rapid development of novel therapies for diseases, including COVID-19.Amerimmune LLC had a discovery early in 2020, showing elevated caspase molecules in peripheral blood immune cells of COVID19 patients. Caspase molecules help build immunity to pathogens, but can also have […]
CIIC Welcomes All Infusion Associates Locations as 26th CIIC Member
December 14, 2022 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization comprised of select US Board-Certified Allergists and Immunologists in private practice, is proud to announce the addition of Infusion Associates (https://infusionassociates.com/) as the 26th member of our network. With over 90 healthcare professionals working in 13 locations, Infusion Associates has further […]
CIIC Welcomes 25th Member: Allergy Partners, PLLC
August 23, 2022 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization comprised of select Board-Certified Allergists and Immunologists in private practice throughout the USA, is proud to announce the addition of Allergy Partners, PLLC as its 25th member to the network. Allergy Partners is the nation’s largest single specialty practice with 136 […]
CIIC HAE Posters Presented at the American College of Allergy, Asthma & Immunology Conference
November, 2022, The American College of Allergy, Asthma & Immunology Conference: CIIC Member Dr. Bill Lumry did a great job presenting our first two Hereditary Angioedema (HAE) Posters, that have resulted from the CIIC – Trio Health partnership. Poster Title: Attack Location and Severity/Resolution In Patients With Hereditary Angioedema (HAE); Observations From Community Immunology Abstract […]